| Filed | Description | |
|---|---|---|
| 12/19/25 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 8/29/25 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 2/14/25 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 11/26/24 | 1.01 Material Agreement | → |
| 3/3/23 | 1.01 Material Agreement | → |
| 9/19/22 | 1.011.022.03 Material Agreement · Agreement Terminated · New Debt Obligation | → |
| ↓ 7 more | ||
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.